New Medicaid Rule Threatens Broader Drug Coverage

The Trump administration's recent rule restricting Medicaid funding for pediatric gender-affirming medications and surgeries could have wider implications. Set to take effect on October 13, this directive not only targets transgender health care but may also pave the way for limiting coverage of other prescription drugs.

Experts warn that this precedent could undermine the expectation that Medicaid will cover most FDA-approved outpatient medications, raising concerns about future access to necessary treatments.

Source: www.statnews.com